Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Journal of Neural Transmission (Vienna, Austria : 1996)|May 5, 2026
Therapeutic botulinum toxin preparations: an updateHans Bigalke, Jürgen Frevert, Dirk Dressler
Journal of Neural Transmission (Vienna, Austria : 1996)|June 28, 2018
Comparing incobotulinumtoxinA (Xeomin®) and onabotulinumtoxinA (Botox®): identical potency labelling in the hemidiaphragm assayDirk Dressler, Lizhen Pan, Hans Bigalke
Journal of Neurology|August 21, 2003
Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failureDirk Dressler, Hans Bigalke, Reiner Benecke
Toxicology|October 3, 2022
The immunology of botulinum toxin therapy: A brief summaryDirk Dressler, Hans Bigalke, Jürgen Frevert
Movement Disorders : Official Journal of the Movement Disorder Society|August 4, 2005
Mouse diaphragm assay for detection of antibodies against botulinum toxin type BDirk Dressler, M Lange, Hans Bigalke
Journal of Neural Transmission (Vienna, Austria : 1996)|March 23, 2016
Botulinum toxin therapy: reduction of injection site pain by pH normalisationDirk Dressler, Fereshte Adib Saberi, Hans Bigalke
Journal of Neural Transmission (Vienna, Austria : 1996)|March 19, 2014
IncobotulinumtoxinA (Xeomin(®)) can produce antibody-induced therapy failure in a patient pretreated with abobotulinumtoxinA (Dysport(®))Dirk Dressler, Fereshte Adib Saberi, Hans Bigalke
Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2014
An enzyme-linked immunosorbent assay for detection of botulinum toxin-antibodiesDirk Dressler, Frank Gessler, Pawel Tacik, et al.
Pageof 6